Seeing Is Believing

Currently out of the existing stock ratings of Yatin Suneja, 301 are a BUY (86.74%), 45 are a HOLD (12.97%), 1 are a SELL (0.29%).
Analyst Yatin Suneja, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 46.5% that have a potential upside of 57.75% achieved within 292 days.
Yatin Suneja’s has documented 638 price targets and ratings displayed on 59 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARGX, argenx NV ADR at 24-Jul-2026.
Analyst best performing recommendations are on ABVX (ABIVAX SA AMERICAN DEPOSITARY SHARES).
The best stock recommendation documented was for IMVT (IMMUNOVANT ) at 9/22/2023. The price target of $32 was fulfilled within 4 days with a profit of $11.61 (56.94%) receiving and performance score of 142.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Apr-2025
$36
$11.16 (44.93%)
$26
11 days ago
(21-Jul-2026)
4/5 (80%)
$10.57 (41.57%)
144
Hold Since 20-Jun-2022
$25
$0.16 (0.64%)
$24
11 days ago
(21-Jul-2026)
18/20 (90%)
$-0.43 (-1.69%)
119
Buy Since 23-Jun-2025
$36
$11.16 (44.93%)
$30
25 days ago
(07-Jul-2026)
0/7 (0%)
$9.8 (37.40%)
Buy Since 30-Jun-2026
$30
$5.16 (20.77%)
$29
1 months 2 days ago
(30-Jun-2026)
10/13 (76.92%)
$4.7 (18.58%)
275
Buy Since 21-Oct-2025
$35
$10.16 (40.90%)
$32
1 months 3 days ago
(29-Jun-2026)
0/4 (0%)
$9.8 (38.89%)
Which stock is Yatin Suneja is most bullish on?
Which stock is Yatin Suneja is most reserved on?
What Year was the first public recommendation made by Yatin Suneja?